Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities

NCT01975480 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: Desvenlafaxine

Sponsor

START Clinic for Mood and Anxiety Disorders